当前位置: 首页 >> 检索结果
3361. Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.
作者: John W Eikelboom.;Daniel J Quinlan.;Shamir R Mehta.;Alexander G Turpie.;Ian B Menown.;Salim Yusuf.
来源: Circulation. 2005年112卷25期3855-67页
There is uncertainty about the role of intravenous unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) in patients with ST-elevation myocardial infarction (STEMI) treated with aspirin and thrombolysis.
3362. Tuberculous pericarditis.
The incidence of tuberculous pericarditis is increasing in Africa as a result of the human immunodeficiency virus (HIV) epidemic. The primary objective of this article was to review and summarize the literature on the pathogenesis, diagnosis, and management of tuberculous pericarditis.
3363. Impact of human immunodeficiency virus infection on cardiovascular disease in Africa.
Human immunodeficiency virus (HIV) infection is the single greatest health challenge facing Africa today. However, the impact of the HIV epidemic on the cardiovascular system in Africans has received scant attention in the world literature.
3364. Rheumatic and nonrheumatic valvular heart disease: epidemiology, management, and prevention in Africa.
Unlike the Western world, valvular disease ranks among the major cardiovascular afflictions in Africa. Acute rheumatic fever and chronic rheumatic valvular disease in their most virulent form are still commonly encountered and impose a huge burden on limited healthcare resources.
3365. Epidemiology and etiology of cardiomyopathy in Africa.
Cardiomyopathy, an often irreversible form of heart muscle disease that is associated with a dismal outcome, is endemic in Africa. The primary objective of this review was to summarize the current state of knowledge on the epidemiology and etiology of cardiomyopathy in people living in Africa and to identify new avenues for research.
3366. Hypertension in sub-Saharan African populations.
Hypertension in sub-Saharan Africa is a widespread problem of immense economic importance because of its high prevalence in urban areas, its frequent underdiagnosis, and the severity of its complications.
3370. Medical director responsibilities for outpatient cardiac rehabilitation/secondary prevention programs: a scientific statement from the American Heart Association/American Association for Cardiovascular and Pulmonary Rehabilitation.
作者: Marjorie L King.;Mark A Williams.;Gerald F Fletcher.;Neil F Gordon.;Meg Gulanick.;Carl N King.;Arthur S Leon.;Benjamin D Levine.;Fernando Costa.;Nanette K Wenger.; .; .
来源: Circulation. 2005年112卷21期3354-60页 3372. Accelerated atherosclerosis in autoimmune rheumatic diseases.
作者: Yehuda Shoenfeld.;Roberto Gerli.;Andrea Doria.;Eiji Matsuura.;Marco Matucci Cerinic.;Nicoletta Ronda.;Luis J Jara.;Mahmud Abu-Shakra.;Pier Luigi Meroni.;Yaniv Sherer.
来源: Circulation. 2005年112卷21期3337-47页 3373. Managing abnormal blood lipids: a collaborative approach.
作者: Barbara Fletcher.;Kathy Berra.;Phil Ades.;Lynne T Braun.;Lora E Burke.;J Larry Durstine.;Joan M Fair.;Gerald F Fletcher.;David Goff.;Laura L Hayman.;William R Hiatt.;Nancy Houston Miller.;Ronald Krauss.;Penny Kris-Etherton.;Neil Stone.;Janet Wilterdink.;Mary Winston.; .; .; .; .; .; .; .; .; .
来源: Circulation. 2005年112卷20期3184-209页
Current data and guidelines recommend treating abnormal blood lipids (ABL) to goal. This is a complex process and requires involvement from various healthcare professionals with a wide range of expertise. The model of a multidisciplinary case management approach for patients with ABL is well documented and described. This collaborative approach encompasses primary and secondary prevention across the lifespan, incorporates nutritional and exercise management as a significant component, defines the importance and indications for pharmacological therapy, and emphasizes the importance of adherence. Use of this collaborative approach for the treatment of ABL ultimately will improve cardiovascular and cerebrovascular morbidity and mortality.
3375. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis.
作者: Nadia A Khan.;Brenda R Hemmelgarn.;Marcello Tonelli.;Christopher R Thompson.;Adeera Levin.
来源: Circulation. 2005年112卷20期3088-96页
The prognostic usefulness of troponin enzymes in end-stage renal disease (ESRD) patients is controversial. To resolve this uncertainty of troponin as a prognostic tool, we conducted a systematic review to quantify the association between elevated troponin I or T and long-term total mortality among ESRD patients not suspected of having acute coronary syndrome.
3378. Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry.
作者: Jason W Ryan.;Eric D Peterson.;Anita Y Chen.;Matthew T Roe.;E Magnus Ohman.;Christopher P Cannon.;Peter B Berger.;Jorge F Saucedo.;Elizabeth R DeLong.;Sharon-Lise Normand.;Charles V Pollack.;David J Cohen.; .
来源: Circulation. 2005年112卷20期3049-57页
Recent studies indicate that a routine invasive approach for patients with unstable angina (UA) and non-ST-segment elevation myocardial infarction (NSTEMI) yields improved outcomes compared with a conservative approach, but the optimal timing of this approach remains open to debate.
3379. Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials.
作者: Laura Mauri.;E John Orav.;Susana C Candia.;Donald E Cutlip.;Richard E Kuntz.
来源: Circulation. 2005年112卷18期2833-9页
Binary angiographic and clinical restenosis rates can vary widely between clinical studies, even for the same stent, influenced heavily by case-mix covariates that differ among observational and randomized trials intended to assess a given stent system. We hypothesized that mean in-stent late loss might be a more stable estimator of restenosis propensity across such studies.
3380. Relationship between procedure indications and outcomes of percutaneous coronary interventions by American College of Cardiology/American Heart Association Task Force Guidelines.
作者: H Vernon Anderson.;Richard E Shaw.;Ralph G Brindis.;Lloyd W Klein.;Charles R McKay.;Michael A Kutcher.;Ronald J Krone.;Michael J Wolk.;Sidney C Smith.;William S Weintraub.
来源: Circulation. 2005年112卷18期2786-91页
An American College of Cardiology/American Heart Association (ACC/AHA) Task Force periodically revises and publishes guidelines with evidence-based recommendations for appropriate use of percutaneous coronary intervention (PCI). Some studies have suggested that closer adherence to guidelines can reduce variations in care, can improve quality, and may ultimately result in better outcomes, but this finding is incompletely understood. Guidelines themselves must change to be responsive to continuously evolving clinical practice. Our goal here was to investigate whether any relationship existed between the most recent ACC/AHA recommended indications for PCI and short term in-hospital outcomes.
|